Mor administration for assessment of immunological endpoints. Day 42 corresponds to low tumor burden that models minimal residual disease in patients, and day 90 corresponds to advanced tumor burden.Isolation and processing of mouse cellsFollowing sacrifice, peritoneal exudate cells (PECs) were collected by peritoneal lavage with PBS (5? ml, containing 1 FBS and 0.5 mM EDTA). PECs were subjected to red cell lysis with ACK buffer, followed by washing. Cell-free supernatants from peritoneal lavage were frozen for subsequent cytokine measurements. Lymph nodes and spleens were 10457188 also harvested at sacrifice, and single cell suspensions were subjected to red cell lysis and washing. Isolated PECs, splenocytes and lymph node cells were either used within 24 h of harvest for flow cytometry and functional studies or frozen in liquid nitrogen in media containing 20 FBS and 5 DMSO.Materials and Methods Ethics statementAll mice were maintained under specific pathogen free conditions at the animal care facility at Roswell Park Cancer Institute and used in compliance with all relevant laws and institutional guidelines under a protocol approved by the RoswellFlow cytometryFlow cytometry analysis was conducted on a FACScan (Becton Dickinson, Franklin Lakes, NJ). R-Phycoerythrin conjugated antimouse Ly6G and CD8, FITC conjugated anti-mouse Ly6C (BD Lixisenatide supplier Biosciences, San Jose, CA), APC conjugated anti-mouse CD11b, Pacific Blue conjugated anti-mouse CD4, and eFlour 450 conjugated anti-mouse F4/80 (UKI 1 eBioscience, San Diego, CA) mAb, and respective isotype controls were used. Forward scatterMyeloid-Derived Suppressor Cells and NADPH Oxidaseversus side scatter gating was set to include all non-aggregated cells. Gating on CD11b+ cells, the proportion of granulocytic MDSCs (Ly6G+Ly6Clow), monocytic MDSCs (Ly6C+Ly6G2), and macrophages (F4/80+) was determined [2].Functional assaysMDSC function was evaluated based on suppression of stimulated T cell proliferation in co-culture experiments. Myeloid cells from tumor-bearing mice were purified with anti-CD11b magnetic beads using autoMACS according to the manufacturer’s protocol (Miltenyi Biotec Inc., Auburn, CA). Granulocytic MDSCs were column-purified using anti-Ly6G magnetic beads. Following column separation, the purity of cell fractions was analyzed microscopically by Diff-Quick-stained cytospins (Fisher Scientific, Kalamazoo, MI,) and by flow cytometry. Splenocytes from non-tumor-bearing C57BL/6 female mice ?were used as naive T cell targets. Following red cell lysis and washing, splenocytes were incubated with 5 mM carboxyfluoresceindiacetate succinimidyl ester (CFSE; Invitrogen, Grand Island, NY) in PBS for 8 min as previously described [30]. Cells (2.5 or 56105 cells/well) were cultured in triplicate in 96-well plates coated with anti-CD3 (10 mg/ml) mAb (BD Biosciences) and B7.1 antigen (0.5 mg/ml) (R D Systems Inc., Minneapolis, MN). Equal numbers of magnetically separated CD11b2, CD11b+, or Ly6G+ cells isolated from tumor-bearing mice were added. After 72 h of co-culture, cells were collected, labeled with anti-CD4 and anti-CD8 mAb, and analyzed by flow cytometry. The proliferation of CFSE-labeled CD4+ and CD8+ T cells was evaluated by quantification of CFSE dilution staining as described [30]. The primary endpoint was the proportion of CFSE-loaded CD4+ and CD8+ T cells undergoing 1 replication.sion requiring euthanasia was similar in WT and p47phox2/2 mice (Figure 1). Because phagocyte oxidase proteins could h.Mor administration for assessment of immunological endpoints. Day 42 corresponds to low tumor burden that models minimal residual disease in patients, and day 90 corresponds to advanced tumor burden.Isolation and processing of mouse cellsFollowing sacrifice, peritoneal exudate cells (PECs) were collected by peritoneal lavage with PBS (5? ml, containing 1 FBS and 0.5 mM EDTA). PECs were subjected to red cell lysis with ACK buffer, followed by washing. Cell-free supernatants from peritoneal lavage were frozen for subsequent cytokine measurements. Lymph nodes and spleens were 10457188 also harvested at sacrifice, and single cell suspensions were subjected to red cell lysis and washing. Isolated PECs, splenocytes and lymph node cells were either used within 24 h of harvest for flow cytometry and functional studies or frozen in liquid nitrogen in media containing 20 FBS and 5 DMSO.Materials and Methods Ethics statementAll mice were maintained under specific pathogen free conditions at the animal care facility at Roswell Park Cancer Institute and used in compliance with all relevant laws and institutional guidelines under a protocol approved by the RoswellFlow cytometryFlow cytometry analysis was conducted on a FACScan (Becton Dickinson, Franklin Lakes, NJ). R-Phycoerythrin conjugated antimouse Ly6G and CD8, FITC conjugated anti-mouse Ly6C (BD Biosciences, San Jose, CA), APC conjugated anti-mouse CD11b, Pacific Blue conjugated anti-mouse CD4, and eFlour 450 conjugated anti-mouse F4/80 (eBioscience, San Diego, CA) mAb, and respective isotype controls were used. Forward scatterMyeloid-Derived Suppressor Cells and NADPH Oxidaseversus side scatter gating was set to include all non-aggregated cells. Gating on CD11b+ cells, the proportion of granulocytic MDSCs (Ly6G+Ly6Clow), monocytic MDSCs (Ly6C+Ly6G2), and macrophages (F4/80+) was determined [2].Functional assaysMDSC function was evaluated based on suppression of stimulated T cell proliferation in co-culture experiments. Myeloid cells from tumor-bearing mice were purified with anti-CD11b magnetic beads using autoMACS according to the manufacturer’s protocol (Miltenyi Biotec Inc., Auburn, CA). Granulocytic MDSCs were column-purified using anti-Ly6G magnetic beads. Following column separation, the purity of cell fractions was analyzed microscopically by Diff-Quick-stained cytospins (Fisher Scientific, Kalamazoo, MI,) and by flow cytometry. Splenocytes from non-tumor-bearing C57BL/6 female mice ?were used as naive T cell targets. Following red cell lysis and washing, splenocytes were incubated with 5 mM carboxyfluoresceindiacetate succinimidyl ester (CFSE; Invitrogen, Grand Island, NY) in PBS for 8 min as previously described [30]. Cells (2.5 or 56105 cells/well) were cultured in triplicate in 96-well plates coated with anti-CD3 (10 mg/ml) mAb (BD Biosciences) and B7.1 antigen (0.5 mg/ml) (R D Systems Inc., Minneapolis, MN). Equal numbers of magnetically separated CD11b2, CD11b+, or Ly6G+ cells isolated from tumor-bearing mice were added. After 72 h of co-culture, cells were collected, labeled with anti-CD4 and anti-CD8 mAb, and analyzed by flow cytometry. The proliferation of CFSE-labeled CD4+ and CD8+ T cells was evaluated by quantification of CFSE dilution staining as described [30]. The primary endpoint was the proportion of CFSE-loaded CD4+ and CD8+ T cells undergoing 1 replication.sion requiring euthanasia was similar in WT and p47phox2/2 mice (Figure 1). Because phagocyte oxidase proteins could h.
